Aurelium Health Limited 12977089 false 2023-11-01 2024-10-31 2024-10-31 The principal activity of the company is the provision of specialist medical practice activites. Digita Accounts Production Advanced 6.30.9574.0 true false 12977089 2023-11-01 2024-10-31 12977089 2024-10-31 12977089 core:RetainedEarningsAccumulatedLosses 2024-10-31 12977089 core:ShareCapital 2024-10-31 12977089 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 12977089 bus:SmallEntities 2023-11-01 2024-10-31 12977089 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 12977089 bus:FullAccounts 2023-11-01 2024-10-31 12977089 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 12977089 bus:RegisteredOffice 2023-11-01 2024-10-31 12977089 bus:Director2 2023-11-01 2024-10-31 12977089 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 12977089 core:PlantMachinery 2023-11-01 2024-10-31 12977089 countries:EnglandWales 2023-11-01 2024-10-31 12977089 2023-10-31 12977089 2022-11-01 2023-10-31 12977089 2023-10-31 12977089 core:RetainedEarningsAccumulatedLosses 2023-10-31 12977089 core:ShareCapital 2023-10-31 12977089 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 iso4217:GBP xbrli:pure

Registration number: 12977089

Aurelium Health Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 October 2024

 

Aurelium Health Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Aurelium Health Limited

(Registration number: 12977089)
Abridged Balance Sheet as at 31 October 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

40,957

46,808

Current assets

 

Debtors

1,214

50

Cash at bank and in hand

 

2,321

3,246

 

3,535

3,296

Creditors: Amounts falling due within one year

(103,716)

(92,066)

Net current liabilities

 

(100,181)

(88,770)

Net liabilities

 

(59,224)

(41,962)

Capital and reserves

 

Called up share capital

500

500

Profit and loss account

(59,724)

(42,462)

Total equity

 

(59,224)

(41,962)

For the financial year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 29 July 2025 and signed on its behalf by:
 

Dr S Patel

Director

 

Aurelium Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 October 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the Board on 29 July 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern
The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or
substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Aurelium Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 October 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and Machinery

10% Straight Line

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 4).

4

Tangible assets

Total
£

Cost or valuation

At 1 November 2023

58,510

At 31 October 2024

58,510

Depreciation

At 1 November 2023

11,702

Charge for the year

5,851

At 31 October 2024

17,553

Carrying amount

At 31 October 2024

40,957

At 31 October 2023

46,808

5

Related party transactions

Dr K S Mangat

During the period Dr K S Mangat went overdrawn on their directors loan account. The maximum overdrawn balance during the year was £1,476(2023- £Nil). At the year end the amount outstanding from was £1,164 (2023- £Nil).